收藏切换
The selection of comparators for health technology assessment: international experience and enlightenment
收藏切换
PDF
Dan-dan AI1, Bin-yan SUI2, Cheng-a-xin DUAN1, Qian XU1, Kun ZHAO3, 4
Chinese Journal of New Drugs | 2023, 32(13) : 1285 - 1292
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(13): 1285-1292
The selection of comparators for health technology assessment: international experience and enlightenment
Full
Dan-dan AI1, Bin-yan SUI2, Cheng-a-xin DUAN1, Qian XU1, Kun ZHAO3, 4
Affiliations
  • 1Beijing Health Economics Association, Beijing 100053, China
  • 2China Health Economics Association, Beijing 100053, China
  • 3China National Health Development Research Center, Beijing 100053, China
  • 4Vanke School of Public Health, Tsinghua University, Beijing 100053, China
Published: 2023-07-15
Outline
收藏切换

The health decision will be impacted by the selection of different comparators that influence the results of the comparative effectiveness and incremental cost-effectiveness analysis. With the application of health technology assessment in assistent of health decision-making, the selection of comparators has gradually received stakeholders' attention. Focusing on the comparators selection, this study systematically reviews the health technology assessment guidelines and comparator selection guidelines published by seven countries and regions including China Taiwan, Japan, the United Kingdom, Germany, Canada, Australia, the United States and international organizations based on a literature review. Meanwhile, taking the selection of comparators as an example in the health technology evaluation report of chimeric antigen receptor T-cell (CAR-T) immunotherapy therapies when applying for medical insurance access in different countries, the international experience is summarized from the selection process, criteria, methods, usage and other dimensions. To deal with the current issues discussed in this study, the decision-making departments and stakeholders need to determine the comparators before the beginning of the evaluation, establish a two-way communication and feedback mechanism, determine the selection criteria and methods based on different decision-making purposes and uses, and select flexible response options for special circumstances, so as to provide reference for optimizing the selection of comparators in drug value evaluation.

comparators  /  health technology assessment  /  international experience  /  chimeric antigen receptor T-cell immunotherapy
Dan-dan AI, Bin-yan SUI, Cheng-a-xin DUAN, Qian XU, Kun ZHAO. The selection of comparators for health technology assessment: international experience and enlightenment[J]. Chinese Journal of New Drugs, 2023 , 32 (13) : 1285 -1292 .
Year 2023 volume 32 Issue 13
PDF
41
18
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-07-15
Article Data
Affiliations
History
  • Accepted:2022-09-13
Affiliations
    1Beijing Health Economics Association, Beijing 100053, China
    2China Health Economics Association, Beijing 100053, China
    3China National Health Development Research Center, Beijing 100053, China
    4Vanke School of Public Health, Tsinghua University, Beijing 100053, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT